Connect with us

Business

Stocks Back Away on United States Fears, Japanese Yen Boosts Nikkei

Published

on

On Thursday i.e. November 15th 2012, Asian market stocks dropped noticeably as shareholders responded to the probability of extensive discussions over the impending United States fiscal cliff by detaching all the risky resources, but equities of Japan clearly challenged the new trend since a well-defined drop in the Japanese Yen boosted market shares of the exporters.

The market shares of Europe were noticed dropping for a 2nd straight day, struck by the recent anxieties of U.S., and its own stubborn debt disaster, with statistics scheduled in the later part of the day more likely to suggest the drop of European region back to its 2nd downturn since 2009 during the 3rd quarter.

The back-off from risk also reflected on commodities, even though oil detained its improvements after starting the last session, owing to increasing stresses in the Middle Eastern parts after Israel government introduced an offensive as opposed to militants belonging to Palestine in Gaza. A seller at the well-known Australian CMC Markets, Ben Taylor said that markets are clearly revealing worse case circumstances at present with shareholders running away in groups, where the prominent market share index dropped to a direct 2 month low.

Stresses that are escalating in almost all parts of the Middle Eastern region added to the fright trading. Asia Pacific’s largest market index, MSCI market shares external to Japan dropped by nearly 1-percent. It has been said that among the losers, market shares of Hong Kong and South Korea are prominent. Emphasizing the major issues of the European region, anti-austerity rallies across the parts of the Southern Europe turned violent on November 14th 2012, while statistics scheduled to be disclosed at 1000 GMT was more likely to display the output of the bloc shrank by almost 0.2-percent during the 3rd quarter.

Challenging the darkness, Nikkei of Tokyo increased by nearly 1.9-percent as the enhancement provided to exporters, including Honda Motors Corporation, Toyota Motors Corp, and Canon Inc overshadowed global concerns. As opposed to the American dollar, the Japanese Yen had dropped considerably on November 15th after Yoshihiko Noda, the Prime Minister of Japan, suggested that he would set up a snap voting during the coming month that the opponent LDP (Liberal Democratic Party), which supports additional financial policy lessening by the Fed, is anticipated to win.

The leading equity strategist working at BNP Paribas, Shun Maruyama recently said that everybody in the nation is hoping LDP’s Shinzo Abe to become the next PM (Prime Minister) of Japan, as he is expected to compel the Bank of Japan to perform brave fiscal easing by placing a two to three percent inflation goal.

Business

Top 3 Gainers: Zynga (NASDAQ:ZNGA), Eros International (NYSE:EROS), Borqs Technologies’ (BRQS)

Published

on

By

Zynga (NASDAQ:ZNGA) is up 2.5% after Benchmark reiterated its Buy rating in a look-ahead at Q2 earnings. The firm’s expecting a beat and solid guidance for Q3, and it’s raising its guidance for the fiscal year.

Tailwinds from the pandemic won’t dissipate easily, Benchmark suggests, and the videogame maker’s acquisition of Peak (and with it new “forever franchises” in Toon Blast and Toy Blast) will drive audience, bookings, margins and free cash flow, it says. The firm has an $11 price target, now implying 14% upside.

Eros International (NYSE:EROS) is up 5.8% today, making up the last week’s lost ground, after news that its streaming service Eros Now is partnering with Sony India (SNE +2.3%).

That will mean Eros Now’s app is pre-installed on selected Sony smart televisions in India, along with availability on a large base of existing models (Bravia E series and newer).

The country over the past year has seen a 25% growth in demand for smart TVs, fueled by overall industry growth of 15%, to a record 15M units/year.

Borqs Technologies’ (BRQS) personal safety tracker sees strong market with increased orders from the electronics retail chain in the US.

The boost in product demand comes ahead coronavirus pandemic that provides company to expect delivery of 250K units this year. It reflects over 3x the volume delivered in 2019, the year of its launch.

Borqs’ mobile personal safety devices designed particularly for senior citizens come with panic button, location tracking, and fall detection.

Continue Reading

Biotech

Biotech movers: Pfizer Inc. (PFE), Celgene Corporation (CELG)

Published

on

Pfizer Inc. (PFE) said on Thursday it received a request for documents as part of a U.S. investigation related to quality issues involving the manufacture of auto-injectors at its Meridian Medical Technologies site.

Pfizer, in a regulatory filing, said it would be producing records in response to the civil investigative demand from the U.S. Attorney’s office for the Southern District of New York.

Why ASDN Could Massively Outperform PFE in 2019

Meridian, a unit of Pfizer that manufactures EpiPen injectors used to deliver an emergency allergy antidote, has been hit by a series of manufacturing problems in recent years. Mylan NV, which markets EpiPens, has recalled tens of thousands of the devices after complaints that some had failed to activate.

Bristol-Myers Squibb has been meeting with shareholders in Boston and New York over the last two weeks to try to salvage its $74 billion purchase of cancer drugmaker Celgene Corporation (CELG), the biggest acquisition announced so far this year.

Why Investors Are Calling ASDN the CELG of the Sky!

The deal, announced in January, was hard sell to Bristol shareholders from the start. The acquisition adds about $32 billion in fresh debt to Bristol’s balance sheet while assuming $20 billion in Celgene’s debt, the companies said at the time. After factoring in debt, the acquisition was the largest health-care deal on record, according to data compiled by Refinitiv.

Now, hedge funds Wellington Management and Starboard Value say the deal doesn’t sit well with them. Bristol has sent executives to New York to meet with institutional investors several times over the last two weeks and met with investors in Boston on Wednesday and Thursday, according to a person who briefed on the meetings.

Bristol-Myers declined to comment.

Continue Reading

Biotech

Big Losers: Corbus Pharmaceuticals Holdings, Inc. (CRBP), Petróleo Brasileiro S.A. – Petrobras (PBR)

Published

on

Corbus Pharmaceuticals Holdings, Inc. (CRBP)’s shares slumped as much as 16% to $6.94 on huge volume. The stock has been showing intense sell off suddenly after a bearish article on seekingalph.com by Alpha Exposure.

The article stated that Corbus has ties to investors convicted of or alleged to have committed securities fraud. We believe lenabasum has failed its major trials in SSc and CF. Lenabasum was also denied Breakthrough Therapy Designation in SSc. We believe lenabasum will fail in its pivotal SSc and Phase 2b CF trials. We are short Corbus with a price target of $0.50.

Wow the future of Autonomous flight is finally here with the launch of ASDN passenger drone Elroy

Petróleo Brasileiro S.A. – Petrobras (PBR) is expanding its ambitious divestment program and has “bold” plans for sales, the Brazilian state-run oil company’s chief executive said after the firm posted its first annual profit in five years.

On a conference call with analysts to discuss fourth-quarter results, CEO Roberto Castello Branco said selling non-core assets will be key to deleveraging.

Petrobras, as the company is known, can reduce its ratio of net debt to earnings before interest, taxes, depreciation and amortization, or EBITDA, to 1.5 or even to 1, he added.

The University of Chicago-educated CEO, who took the reins in early January, has long been vocal about the need to slim down the sprawling firm and focus on core activities such as exploration and production. Thursday’s comments were some of his most assertive on the matter.

Why Investors Are Calling ASDN the TPC of the Sky!

Continue Reading
Advertisement

Trending